- Did you mean
- tla vaccines
Search results - 11 results
Oncolytic Viruses: An Inventory of Shedding Data from Clinical Trials and Elements for the Environmental Risk Assessment.
Publication Type: Peer reviewed scientific article Authors: Onnockx, Sheela; Aline Baldo; Katia Pauwels Source: Vaccines (Basel), Volume 11, Issue 9 (2023) Keywords: biosafety cancer Clinical trials ...
Importance of anti-SARS-CoV-2 assay antigenic composition as revealed by the results of the Belgian external quality assessment (EQA) scheme.
necessity of external quality assessment schedules and importance of antigenic composition of serologic SARS-CoV-2 assays. Health Topics: Effectiveness and safety of vaccines, medicines and health products- ...
Environmental Risk Assessment of Recombinant Viral Vector Vaccines against SARS-Cov-2
Publication Type: Peer reviewed scientific article Authors: Aline Baldo; Amaya Leunda; Nicolas Willemarck; Katia Pauwels Source: Vaccines, Volume 9, Issue 5 (2021) Health Topics: Health and ...
Deepening of In Silico Evaluation of SARS-CoV-2 Detection RT-qPCR Assays in the Context of New Variants
Health Topics: Efficacité et sécurité des vaccins, médicaments et produits de santé- Qualité des laboratoires médicaux Coronavirus Santé et environnement Effectiveness and safety of vaccines, medicines ...
Use of Whole Genome Sequencing Data for a First in Silico Specificity Evaluation of the RT-qPCR Assays Used for SARS-CoV-2 Detection.
of future RT-qPCR tests, as well as verifying that the former methods are still capable of detecting circulating SARS-CoV-2 variants. Health Topics: Effectiveness and safety of vaccines, medicines and ...
DNA vaccines against tuberculosis.
Antigens, Bacterial BCG Vaccine Humans Immunization, Secondary Mycobacterium tuberculosis T-Lymphocytes, Cytotoxic Tuberculosis, Pulmonary Vaccination Vaccines, DNA Abstract: INTRODUCTION: Tuberculosis (TB) ...
Novel GMO-Based Vaccines against Tuberculosis: State of the Art and Biosafety Considerations.
Publication Type: Peer reviewed scientific article Authors: Amaya Leunda; Aline Baldo; Goossens, Martine; Huygen, Kris; Philippe Herman; Marta Romano Source: Vaccines (Basel), Volume 2, Issue 2, ...
Biosafety of viral vectors commonly used in gene therapy and vaccination.
Humans Organisms, Genetically Modified Risk Assessment Vaccination Health Topics: Health and environment Category: A1 FOS Classification: 3.03 Health sciences ...
Environmental risk assessment of clinical trials involving modified vaccinia virus Ankara (MVA)-based vectors.
Animals Clinical Trials as Topic Genetic Therapy Genetic Vectors Hazardous Substances Humans Risk Assessment Vaccination vaccinia virus Viral Vaccines Abstract: The modified vaccinia virus Ankara (MVA) ...
Biosafety aspects of modified vaccinia virus Ankara (MVA)-based vectors used for gene therapy or vaccination.
Publication Type: Peer reviewed scientific article Authors: Verheust, Céline; Goossens, Martine; Katia Pauwels; Didier Breyer Source: Vaccine, Volume 30, Issue 16, p.2623-32 (2012) Keywords: Animals ...